이우인
Wooin Lee, PhD
ORCID
Google scholar profile
ElsevierPURE
Education
Ph.D. University at Buffalo, SUNY
B.S., M.S. Seoul Nat’l Univ.
Professional Experience
Assistant & Associate Professor, Univ. of Kentucky, USA
Postdoctoral Research Fellow, Research Assistant Professor, Vanderbilt Univ., USA
김지영 Jiyoung Kim, MS
(PhD program, 2021 Fall ~)
곽희천 Heechun Kwak, MS
(PhD program, 2019 Fall ~)
이성수 Seongsoo Lee
(MS/PhD program, 2021 Fall ~)
도경민 Kyungmin Do
(MS program, 2024 Spring ~)
변선영 Seonyoung Byoun
(MS program, 2024 Spring ~)
양승아 Seungah Yang
(MS program, 2024 Spring ~)
허나윤 Nayoun Heo
(MS/PhD program, 2025 Spring ~)
이민수 Minsoo Lee
(MS program, 2025 Spring ~)
정유성 Yoo-Seong Jeong, PhD
(2025 Spring ~)
지민지 Min Ji Ji, MS
(PhD program, 2025 Fall ~)
서아란 Aran Seo, MS
(PhD program, 2025 Fall ~)
이정현
(Research Associate, 2025 Fall ~)
Alumni
Nilay Thakkar (PhD, 2010-15) Molecular & Functional Investigations of Cancer-type and Liver-type Variants of Organic Anion Transporting Polypeptide 1B3 (currently at GSK, USA)
Lin Ao (PhD, 2012-16) Investigating Mechanisms Determining Cancer Cell Sensitivity to Carfilzomib and Novel Strategies to Overcome Carfilzomib Resistance
Se Eun Chun (MS, 2015-17) The N-terminal Region of OATP1B3 Plays an Essential Role in Regulating its Plasma Membrane Trafficking (currently at LG Chem)
Yunseok Oh (MS, 2016-18) Inhibition of Organic Anion Transporting Polypeptides (OATP1B1 & 1B3) by Betulinic Acid: Effects of Pre-incubation and Albumin in the Media (currently at Dong-A Pharmaceutical. Co.)
Gongmi Ryoo (MS, 2016-18) Mechanisms Regulating the Expression of Organic Anion Transporting Polypeptide 1B3 (OATP1B3) in Hepatic Cancer Cells: Hypoxia and Epigenetic Alteration
Ji Eun Park (PhD, 2015-19) Pharmacokinetics and pharmacodynamics of novel nanoformulations for the proteasome inhibitor drug carfilzomib: Expanding its therapeutic utility against solid cancers (currently at Florida International University, USA)
Yearin Jun (MS, 2017-19) Pharmacokinetic profiles of quinic acid-conjugated nanoparticles for the proteasome inhibitor drug carfilzomib: Improved in vivo stability and tumoral drug accumulation (currently at Dong-A Pharmaceutical. Co.)
Ji Yoon Choi (MS, 2018 - 20) Impact of histone deacetylase inhibitor romidepsin on the expression and function of organic anion transporter polypeptide 2B1 (OATP2B1) in liver cancer cell lines (currently at 안국약품)
Naeun Yoon (MS, 2018 - 20) Regulation of organic anion-transporting polypeptide 1B3 (OATP1B3) variants in human hepatic cancer cells: Impact of hypoxia-mimicking agents and DNA methyltransferase 1 inhibitors (currently at 한국 MSD)
Jisu Yoo (MS, 2018 - 20) Evaluation of Epoxyketone-based Immunoproteasome-selective Inhibitors with Enhanced Brain Distribution and Stability In Vitro & In Vivo
Hyeryung Jang (MS, 2019 - 21) Pharmacokinetic evaluation of the novel macrocyclic immunoproteasome-selective inhibitor DB55 in mice: Focus on brain penetration and metabolic stability
Jeong-min Ha (MS, 2019 - 21) Impact of the naturally occurring c.421C>A variation of the ATP binding cassette superfamily G member 2 (ABCG2) gene on its protein degradation and dimerization (currently at Samsung Bioepis)
Shinyoung Park (MS, 2023 - 25) Functional Impact of the ABCG2 c.421C>A Variation on Protein Stability and Efflux Activity in vitro (currently at SK Biosciences)
Kyunghwa Kim (2009-2011, a research assistant at UK, currently at CJ Healthcare)
Eun Ryoung Jang, Ph.D. (a postdoc at UK, 2009-11)
Dong-hern Kim, Ph.D. (a postdoc at UK, 2011)
Daniel Machado (UK, an undergrad research student and a research assistant, 2009-12)
Songhee Han, Ph.D. (an exchange student at UK, 2011-2012; a postdoc at SNU, 2015-16; currently at 환인제약)
Kyungbo Kim (2012-2013, currently a project leader at BiomedX, Germany)
Youngran Lim (Konkuk University, an exchange student at UK, 2012-13)
contact us at: wooin.lee@snu.ac.kr